We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WY icon
326
Weyerhaeuser
WY
$17.3B
$1.73M 0.05%
58,169
-224,221
-79% -$6.9M
BF.B icon
327
Brown-Forman Class B
BF.B
$12B
$1.73M 0.04%
54,056
+31,322
+138% +$969K
ITW icon
328
Illinois Tool Works
ITW
$81.4B
$1.72M 0.04%
16,532
-397
-2% -$41.6K
NVAX icon
329
Novavax
NVAX
$1.23B
$1.69M 0.04%
+11,636
New +$1.33M
DTE icon
330
DTE Energy
DTE
$31.1B
$1.68M 0.04%
19,913
-23,937
-55% -$1.85M
BLK icon
331
Blackrock
BLK
$164B
$1.67M 0.04%
4,868
+631
+15% +$222K
PGR icon
332
Progressive
PGR
$124B
$1.67M 0.04%
49,766
+671
+1% +$22.2K
GHDX
333
DELISTED
Genomic Health, Inc.
GHDX
$1.63M 0.04%
63,000
-37,000
-37% -$983K
SPGI icon
334
S&P Global
SPGI
$126B
$1.62M 0.04%
+15,120
New +$1.62M
D icon
335
Dominion Energy
D
$62.5B
$1.62M 0.04%
20,749
+3,618
+21% +$263K
EXC icon
336
Exelon
EXC
$48.6B
$1.61M 0.04%
62,040
+10,228
+20% +$253K
GWW icon
337
W.W. Grainger
GWW
$65.3B
$1.61M 0.04%
7,075
+1,774
+33% +$404K
TTPH
338
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.61M 0.04%
18,700
+4,500
+32% +$412K
MFC icon
339
Manulife Financial
MFC
$72.6B
$1.58M 0.04%
116,008
-1,132
-1% -$16.1K
ICE icon
340
Intercontinental Exchange
ICE
$82.4B
$1.53M 0.04%
29,930
+3,505
+13% +$177K
ACOR
341
DELISTED
Acorda Therapeutics
ACOR
$1.53M 0.04%
500
– –
PTLA
342
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.52M 0.04%
64,500
-12,000
-16% -$296K
BAX icon
343
Baxter International
BAX
$11.6B
$1.52M 0.04%
33,524
+3,966
+13% +$174K
FAST icon
344
Fastenal
FAST
$54B
$1.51M 0.04%
135,780
+1,632
+1% +$18.6K
MAR icon
345
Marriott International
MAR
$98.7B
$1.49M 0.04%
22,350
-28,393
-56% -$1.9M
BWA icon
346
BorgWarner
BWA
$13.2B
$1.48M 0.04%
57,091
-34,330
-38% -$1.04M
UTHR icon
347
United Therapeutics
UTHR
$26.3B
$1.48M 0.04%
14,000
-4,000
-22% -$446K
CSX icon
348
CSX Corp
CSX
$98.6B
$1.48M 0.04%
170,037
-990,204
-85% -$8.62M
DNB
349
DELISTED
Dun & Bradstreet
DNB
$1.47M 0.04%
12,083
+2,393
+25% +$280K
GWPH
350
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.47M 0.04%
+16,000
New +$1.35M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.